Diabetes
Shortages, discontinuations seeing people on multiple medications
Semaglutide scarcity and other similar shortages have led to people doubling up on treatments, says diabetes educator and pharmacist Medicines shortages and discontinuations are leading to people concurrently taking multiple …
Oral versions of GLP-1s on the horizon
With benefits beyond glucose control for the “new kid on the block” in diabetes management, leading researcher foreshadows oral versions with less side effects New versions of GLP-1 receptor agonists …
Type 2 diabetes in older people living in the community
The management of diabetes in older people presents unique challenges due to multiple factors including comorbidities, polypharmacy, frailty, and age-related physiological changes. By Dr Jenny Gowan AM, PhD, Grad Dip …
Realigning diabetes regimens
Australian guidelines for the management of type 2 diabetes state that overtreatment of diabetes is common in older adults and should be avoided.1 Deintensification or simplification of complex regimens is …
Dietary advice and nutritional support for patients with chronic conditions
Poor dietary habits and sedentary lifestyles can significantly contribute to global burden of disease, particularly non-communicable diseases such as hypertension, diabetes mellitus and hyperlipidaemia.1 Pharmacists are well-positioned to educate and …
Preventing diabetes complications
The key aim of diabetes management is to prevent complications, which are a major cause of morbidity and mortality. By Debbie Rigby, advanced practice pharmacist Learning Objectives After completing this …
Identifying complications of diabetes: the pharmacist’s role
This article discusses the various medical conditions that may occur more frequently with, or as a complication of diabetes. By Karalyn Huxhagen BPharm, FPS, FANZCAP (CommPharm, PrimCare), community pharmacist and …
Research roundup
Debbie Rigby rounds up the latest in research news Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes This …
Limited PBS access, shortages may impact add-on therapy
Prevalence of add-on therapy in people with type 2 diabetes is “low” and should be increased to save lives, PBS records analysis finds More Australians with type 2 diabetes need …
Diabetes in older persons
The increasing prevalence of type 2 diabetes among older persons highlights the need for pharmacists conducting medication reviews to remain up to date with shifting evidence and guidelines. By Debbie …
Helping people with diabetes to live well
With an expanding number of medications and new technologies, pharmacists play a vital role in supporting patients with diabetes, says Leanne Philpott Around 1.5 million Australians are living with diabetes. …
Inquiry backs expansion of GLP-1 RA eligibility
Government urged to make Glucagon-like Peptide-1 receptor agonists (GLP-1 RAs) available to more patients Steps to improve access to GLP-1 RAs for high-risk patients are among 23 recommendations in the …